Effects of a Periodic Repetitive Transcranial Magenetic Stimulation in Parkinson Disease

NAActive, not recruitingINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

April 6, 2020

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Transcranial Magnetic StimulationParkinson's Disease
Interventions
OTHER

transcranial magnetic stimulation

During treatment, the patient underwent cTBS targeting the left SMA for 14 consecutive days. Each treatment day comprised three rounds of cTBS, with a 15-minute interval between each. A single cTBS session involved trains of three pulses at 50 Hz, repeated every 200 ms (5 Hz), until reaching a total of 600 pulses, lasting 40s. Stimulation intensity remained at 80% of resting motor threshold. In total, patients received 25,200 pulses throughout the treatment period.

DRUG

Pharmacotherapy(antiparkinsonian drugs)

Anti-Parkinson's disease drugs include compound levodopa, dopamine receptor agonists, monoamine oxidase type B inhibitors, catechol-O-methyl transferase inhibitors, etc. Take dopaminergic agents regularly, with follow-up every 8 weeks including medication guidance and symptom assessment

Trial Locations (1)

230022

Cognitive Neuropsychology Lab Anhui Medical University, Hefei

All Listed Sponsors
lead

Anhui Medical University

OTHER